Management of gastrointestinal involvement in scleroderma

Area of Science:

• Gastroenterology
• Rheumatology
• Internal Medicine

Background:

• Gastrointestinal tract (GIT) involvement is a common and heterogeneous complication in systemic sclerosis (SSc).
• Manifestations range from asymptomatic disease to severe dysmotility, leading to malabsorption, weight loss, and malnutrition.
• Effective management strategies are crucial for improving patient outcomes.

Purpose of the Study:

• To provide a comprehensive overview of the management of gastrointestinal involvement in systemic sclerosis.
• To categorize management approaches based on the specific segment of the GIT affected.
• To incorporate the role of patient-reported outcome measures in assessing SSc-GI complications.

Main Methods:

• Literature review focusing on the management of gastrointestinal complications in systemic sclerosis.
• Categorization of management strategies according to the affected GIT segment (e.g., esophagus, stomach, small intestine, large intestine).
• Inclusion of a discussion on patient-reported outcome measures relevant to SSc-GI involvement.

Main Results:

• Gastrointestinal involvement in SSc presents a wide spectrum of clinical manifestations.
• Management strategies are tailored to the specific GIT segment and the severity of symptoms.
• Patient-reported outcome measures offer valuable insights into the patient's experience and treatment effectiveness.

Conclusions:

• Systemic sclerosis-related gastrointestinal dysfunction requires a multi-faceted management approach.
• Segment-specific therapeutic interventions are essential for addressing diverse GIT manifestations.
• Integrating patient-reported outcomes enhances the comprehensive care of SSc patients with GI involvement.